Septabene 1.5 mg/ml + 5 mg/ml sumute suuonteloon, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

septabene 1.5 mg/ml + 5 mg/ml sumute suuonteloon, liuos

krka, d.d., novo mesto - benzydamine hydrochloride, cetylpyridinium chloride - sumute suuonteloon, liuos - 1.5 mg/ml + 5 mg/ml - bentsydamiini

Phelinun União Europeia - finlandês - EMA (European Medicines Agency)

phelinun

adienne s.r.l. s.u. - melphalan hydrochloride - multiple myeloma; hodgkin disease; lymphoma, non-hodgkin; precursor cell lymphoblastic leukemia-lymphoma; leukemia, myeloid, acute; neuroblastoma; ovarian neoplasms; hematopoietic stem cell transplantation - antineoplastiset aineet - high-dose of phelinun used alone or in combination with other cytotoxic medicinal products and/or total body irradiation is indicated in the treatment of:multiple myeloma,malignant lymphoma (hodgkin, non-hodgkin lymphoma),acute lymphoblastic and myeloblastic leukemia,childhood neuroblastoma,ovarian cancer,mammary adenocarcinoma. phelinun in combination with other cytotoxic medicinal products is indicated as reduced intensity conditioning (ric) treatment prior to allogeneic haematopoietic stem cell transplantation (allo-hsct) in malignant haematological diseases in adults. phelinun in combination with other cytotoxic medicinal products is indicated as conditioning regimen prior to allogeneic haematopoietic stem cell transplantation in haematological diseases in the paediatric population as:myeloablative conditioning (mac) treatment in case of malignant haematological diseasesric treatment in case of non-malignant haematological diseases.

Dexamethasone phosphate Kabi 4 mg/ml injektioneste, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

dexamethasone phosphate kabi 4 mg/ml injektioneste, liuos

fresenius kabi ab - dexamethasone sodium phosphate - injektioneste, liuos - 4 mg/ml - deksametasoni

Pepaxti União Europeia - finlandês - EMA (European Medicines Agency)

pepaxti

oncopeptides ab - melphalan flufenamide hydrochloride - multiple myeloma - antineoplastiset aineet - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.

Thalidomide Lipomed União Europeia - finlandês - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - talidomidin - multiple myeloma - immunosuppressantit - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

Epysqli União Europeia - finlandês - EMA (European Medicines Agency)

epysqli

samsung bioepis nl b.v. - ekulitsumabi - hemoglobinuria, paroxysmal - immunosuppressantit - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Bekemv União Europeia - finlandês - EMA (European Medicines Agency)

bekemv

amgen technology (ireland) uc - ekulitsumabi - hemoglobinuria, paroxysmal - immunosuppressantit - bekemv is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). todisteita kliininen hyöty on osoitettu potilailla, joilla on hemolyysi kanssa kliinisiä oireita(s) osoittaa korkea taudin aktiivisuus, riippumatta siitä, verensiirtoon historia (ks. kohta 5.

Klexane 100 mg/ml injektioneste, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

klexane 100 mg/ml injektioneste, liuos

sanofi oy - enoxaparin sodium - injektioneste, liuos - 100 mg/ml - enoksapariini

Gammagard S/D infuusiokuiva-aine ja liuotin, liuosta varten Finlândia - finlandês - Fimea (Suomen lääkevirasto)

gammagard s/d infuusiokuiva-aine ja liuotin, liuosta varten

baxalta innovations gmbh - human normal immunoglobulin - infuusiokuiva-aine ja liuotin, liuosta varten - ihmisen normaali immunoglobuliini intravaskulaariseen käyttöön

Klexane Cum Conservans 100 mg/ml injektioneste, liuos Finlândia - finlandês - Fimea (Suomen lääkevirasto)

klexane cum conservans 100 mg/ml injektioneste, liuos

sanofi oy - enoxaparin sodium - injektioneste, liuos - 100 mg/ml - enoksapariini